Facebook Fallout Intensifies, Weinstein Co. Files for Bankruptcy
The fallout from Facebook's latest data scandal continues to intensify. Reports emerged late Monday that Facebook's chief security officer is leaving the company later this year amid a dispute over how the company handles the spread of misinformation. In response to the reports, Alex Stamos said on Twitter that he is “still fully engaged" with his work at Facebook. Criticism of the social networking company is growing after it came to light that the data firm Cambridge Analytica gained access to information on 50 million Facebook users without their knowledge.
The Weinstein Co. officially files for bankruptcy protection after many attempts to sell the company failed. The Dallas-based Lantern Capital Partners firm is acquiring the company's assets. The Weinstein Co. is also ending all non-disclosure agreements with women who were forced to stay silent up until now, and encouraging those women to speak up. This follows numerous sexual assault allegations against the company's co-founder Harvey Weinstein.
We spoke with a farmer about how tariffs, trade policy, drought, and packer consolidation are reshaping the economics of American ranching and farming.
John Serafini, CEO of Hawkeye 360, breaks down the company’s 87% revenue growth, global demand for space-based intelligence and plans to scale its business.
Dan Niles, Founder and Portfolio Manager at Niles Investment Management, breaks down NVIDIA’s blowout earnings, 70% growth forecast and AI spending boom.
Edwin Cywinski, CEO of SunScout Holding Limited, explains how solar-powered robotic mowers are transforming lawn care and the company’s plans to scale.
Nathan Bomey, Business Reporter at Axios and author of The Axios Closer newsletter, explains why Wall Street is turning NVIDIA’s AI chips into financial assets.
Jamie Siminoff, Founder and Chief Inventor of Ring, explains the company’s new TAKE encryption standard and its push to put privacy and video data control first
Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.